2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Dutasteride: new trials by email Literature Review of Dutasteride trials Research Report on Dutasteride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PCUR-101 in Combination With ADT in Patients With mCRPC PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone - Prostate Cancer | Phase 1 | Terminated | Pellficure Pharmaceuticals, Inc | 7 | 2021-03-30 | 2024-04-10 |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer ketoconazole, hydrocortisone, dutasteride - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Dana-Farber Cancer Institute | 11 | 2009-09-29 | 2018-09-04 |
Dana-Farber Cancer Institute (1) · Pellficure Pharmaceuticals, Inc (1)
United States (2) · Australia (1)
Glenn Bubley, MD (1)